INTRODUCTION
During the development of the mammalian neocortex, neuronal progenitors located in the ventricular and subventricular zones (VZ and SVZ, respectively) of the dorsal telencephalon give rise to multiple projection neurons that are arranged in six cortical layers in the mature brain. Neurons within each layer are generated at similar times and share similar morphology and patterns of connectivity. Neurons of upper layers 2 and 3 interconnect different cortical areas ipsilaterally or contralaterally. Layer 4 is the major input layer, while most neurons of deep layers 5 and 6 send their axons to subcortical targets in the spinal cord, pons, tectum, and thalamus. During neurogenesis, deep layers are generated first, followed by neurons of layers 4, 3, and 2. Neocortical progenitors become progressively restricted in their potential to produce different cell types, hence late progenitors can only generate upper-layer (UL) neurons, not deep-layer (DL) neurons (Desai and McConnell, 2000; McConnell and Kaznowski, 1991) .
Great progress has been made in identifying genes that control the early aspects of cortical progenitor specification. Pax6, Emx2, and Foxg1 have been shown to be involved in the initial specification of neocortical cell fate (for review see Mallamaci and Stoykova, 2006) , whereas Tbr1, Fezf2 (also known as Fezl or Zfp312), and Ctip2 (Bcl11b) are known to be involved in postmitotic specification of DL neurons. Tbr1 regulates the differentiation of layer 6 and subplate (Hevner et al., 2001) . A lack of Fezf2 leads to depletion of corticospinal motor neurons (Chen et al., 2005a (Chen et al., , 2005b Molyneaux et al., 2005) . In Ctip2 mutant mice, the most obvious change in the neocortex is the misrouting of layer 5 axons . It has been shown that the deletion of transcription factors Pax6 or Tlx, or a double knockout of Brn1 (Pou3f3) and Brn2 (Pou3f2), causes a reduction in UL neuron production in the neocortex (McEvilly et al., 2002; Roy et al., 2004; Sugitani et al., 2002; Tarabykin et al., 2001) . Little is known, however, about the identity of genes controlling the postmitotic specification of UL neurons.
Several cut domain transcription factors that are expressed by young UL neurons during the initial steps of their specification have been recently identified. Cux1 (Cutl1) and Cux2 (Cutl2) appear to be expressed by all UL neurons, while Satb2 is expressed in a subgroup of UL cells (Britanova et al., 2005 (Britanova et al., , 2006a Nieto et al., 2004; Zimmer et al., 2004) .
Satb2 is closely related to Satb1, a protein that was originally identified as a protein interacting with specialized AT-rich DNA sequences (MARs/SARs and BURs). It has been demonstrated that Satb1 controls the expression of multiple genes (Alvarez et al., 2000; Cai et al., 2003 Cai et al., , 2006 de Belle et al., 1998; Yasui et al., 2002) . Satb2 has been also shown to bind AT-rich DNA sequences (Britanova et al., 2005; Dobreva et al., 2003; Szemes et al., 2006) and to interact with chromatin remodeling complexes (Gyorgy et al., 2008) . Inactivation of Satb2 leads to perinatal lethality most likely as a result of multiple craniofacial abnormalities (Britanova et al., 2006b; Dobreva et al., 2006) .
In a previous study, we identified Satb2 as a gene that is expressed predominantly in young UL neurons but not in SVZ progenitors (Britanova et al., 2005) . Its expression pattern suggests that Satb2 may be involved in the control of early aspects of UL neuron specification. To test this hypothesis, we analyzed the neocortical development in Satb2 À/À mice. We found that in the absence of Satb2 expression, UL neurons lose their UL identity, and a genetic program normally silent in these neurons but reminiscent of DL neurons is activated. Moreover Satb2 À/À mice failed to form a corpus callosum, a fiber tract formed largely by UL neurons. In the absence of Satb2, some of the UL neurons contribute to the corticospinal tract, which is normally populated by layer 5 axons. Additionally, UL neurons in Satb2 mutants failed to migrate to the superficial cortical plate (CP) and instead settled in the deeper CP. We conclude that Satb2, through chromatin remodeling, is required to initiate the UL-specific genetic program and suppress expression of DL-specific genes.
RESULTS

Satb2, Ctip2 and Svet1 Label Distinct Neuronal Populations during Cortical Development
Starting from E13.5, Satb2 is predominantly expressed in the UL neurons of the neocortex. The majority of neocortical Satb2+ neurons are born between E14.5 and E15.5 in the dorsal telencephalon, although there are a few Satb2+ cells in the CP already by E13.5 (Britanova et al., 2005 (Britanova et al., , 2006a . At E15.5, most Satb2+ cells did not express Tbr1, which in turn is produced at high levels in the subplate and layer 6. Notably, at this age some UL neurons express Svet1, another UL neuron marker (Britanova et al., 2006a; Hevner et al., 2001; Tarabykin et al., 2001) .
To more precisely relate Satb2 protein expression to specific neocortical subtypes, we analyzed the colocalization of Satb2 with Brn2 and Ctip2 by double immunohistochemistry (IHC). Brn2 and Brn1 are expressed in both UL progenitors and postmitotic neurons and have very similar expression patterns (McEvilly et al., 2002; Sugitani et al., 2002) . At P0, most cells in the intermediate zone (IZ) and CP coexpress Satb2 and Brn2, although there are also two minor cell populations in which either Satb2 or Brn2 (see Figure S1 available online) is detectable.
Ctip2 is a transcription factor that is produced by many cortical plate neurons at the early stages of corticogenesis. At later stages, it is expressed at high levels and is confined to layer 5 neurons that project to the spinal cord and tectum and excluded from the callosally projecting population . At E13.5, a small number of Satb2+ cells are found within the CP, but these are greatly outnumbered by Ctip2+ cells in this region (Figures 1A and 1B) . Most Satb2+ neurons at this stage also coexpress Ctip2. In contrast, at E15.5, the number of Satb2+ cells increases and most do not coexpress Ctip2 ( Figure 1C ). Doublelabeled cells are found in the lower part of the Satb2 domain at this age, suggesting that they represent the same cell population that coexpresses both genes at E13.5. At E17.5 (data not shown) and P0 ( Figure 1D ), there are very few cells that coexpress both proteins, and those that do are located in the lower part of the Satb2 domain. Interestingly, cells that coexpress both Ctip2 and Satb2 only express the latter at very low levels ( Figure 1 ). These results suggest that Satb2 and Ctip2 control mutually exclusive genetic programs of UL and DL cell-type specification.
Svet1 is a marker of a subpopulation of upper-layer cells. These cells reside in the SVZ for a prolonged period prior to starting their migration. They begin entering the CP at E18.5 and complete their migration by P2 (Tarabykin et al., 2001) . To address whether Satb2 and Svet1 are expressed in the same cells, we combined IHC with Satb2 antibody and nonradioactive in situ hybridization with Svet1 probe. We specifically analyzed developmental stages from E17.5 to P2 when both genes are coexpressed in the CP. We did not detect any colocalization in the SVZ and IZ at these stages. Most cells in the CP that expressed Svet1 at high levels at P0 or P2 did not express Satb2 ( Figures 1E-1G and Figure S2 ). We cannot completely rule out the possibility that there are some neurons in the CP that coexpress both genes because of the nuclear nature of Satb2 staining and cytoplasmic staining of Svet1. Although we never detected overlap between the two, in some cases we detected weak Svet1 signal in close proximity to Satb2 nuclei, indicating that some cells may coexpress both genes in the CP.
Our results suggest that patterns of Satb2, Ctip2, and Svet1 expression can distinguish at least three classes of neurons in the cortical plate. In addition, a population exists that expresses Ctip2 strongly and Satb2 weakly, as well as a population of Svet1+ cells that are likely to coexpress Satb2. However, our data suggest that two populations of UL neurons can be distinguished by their exclusive expression of Satb2 and Svet1.
Satb2 Protein Expression Is Not Activated Immediately after Mitotic Cycle Exit
We have shown previously that Satb2 is not expressed in proliferating cells within the dorsal telencephalon (Britanova et al., 2005; Szemes et al., 2006) . To address whether Satb2 is expressed immediately after cells exit from cell cycle or at a later time point, we injected BrdU into E15.5 pregnant female mice and analyzed BrdU/Satb2 colocalization at 6, 12, and 24 hr after the BrdU pulse. The length of S phase and G2 + M phases at this stage is estimated to be 4 and 2 hr, respectively (Takahashi et al., 1995) . Accordingly, 2 hr after BrdU injection can be considered a mitotic exit point for those cells labeled at the end of S phase and 6 hr for all BrdU+ postmitotic cells. Double-IHC 6 hr after injection did not reveal any BrdU/Satb2+ cells. Very few cells were positive for both BrdU and Satb2 12 hr after injection, but the number of BrdU/Satb2+ cells further increased by 24 hr after injection ( Figure 2G and Figure S3 ). Hence, the ''postmitotic waiting period'' for the first onset of Satb2 protein expression can be approximated as minimally 9-10 hr after the last cell division.
These experiments together with the Satb2/Ctip2 double staining suggest that Satb2 marks a distinctive subpopulation of UL neurons. Satb2 was not present in new-born neurons for at least 9 hr after mitotic cycle exit, but the expression was high during neuronal migration and axonal growth. This suggests that Satb2 may be involved in the control of laminar cell-type identity, including connectivity.
Cre Recombinase Expression Resembles Satb2 Expression in Satb2
Cre/+ Brains The expression data above motivated us to investigate the cortical development in animals lacking Satb2 (Britanova et al., 2006b was not completely lost in the developing spinal cord (Britanova et al., 2006b ). Next we addressed whether Satb2 was absent from the neocortex of Satb2 À/À mice. We used two Satb2-specific antibodies raised against different parts of Satb2 protein: Ab1 and Ab2 (Britanova et al., 2005) . While Ab1 antibody did not reveal any staining in the Satb2 À/À brains, the Ab2 antibody showed reactivity in scattered cells in the developing cortex.
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Satb2 protein varied between different areas of the mutant neocortex and among different animals. Two extreme examples of such variations are shown in Figure S4 . In order to address whether this might be the result of targeted exon exclusion during mRNA splicing, we performed E16.5. Given our previous finding that the Satb2 mutation induces elevated cell death in the brachial arches (Britanova et al., 2006b ), we investigated cell death in the neocortex of Satb2 mutants. The extent of apoptotic cell death in the cortical tissue of WT, heterozygous, and KO animals was analyzed using the TUNEL assay at E15.5 and E17.5. The analysis did not reveal any differences in the level of apoptotic cell death in WT, heterozygote, or KO mice (data not shown).
Satb2 Mutants Fail to Form the Corpus Callosum, but Retain Both Hippocampal and Anterior Commissures
Analysis of Nissl-stained Satb2 À/À brains shows malformations in two of the major axonal tracts interconnecting the cortical hemispheres: the corpus callosum (c.c) and the anterior commissure (a.c). The c.c was absent in Satb2 À/À mice (n = 30) but was always present in heterozygotes (n = 10) and WT (n = 30) animals. On the other hand, the a.c was consistently thicker ( Figures 3A-3D ). The hippocampal commissure, a bundle of axons located caudal to the c.c, was not affected. The lack of the corpus callosum is a frequent consequence of the loss of genes involved in cortical development. Usually this defect coincides with the formation of Probst bundles, which consist of fibers that fail to cross the midline. We did not detect any Probst bundles or accumulation of fibers in the vicinity of the midline. This was confirmed by IHC staining of L1, a CAM family member of adhesion molecules that labels cortical axons (Fukuda et al., 1997; Molnar et al., 2002) . L1 labels axonal fibers, both IZ and callosal fibers, in WT animals, but L1 callosal staining was not detected in the mutant brains. There was no excessive L1 staining in the vicinity of the midline, as would have been expected in the case of Probst bundle formation ( Figures 3E and 3F ).
The absence of the corpus callosum and a thickened anterior commissure in KO mice prompted us to study the commissural projections using lipophilic tracers: DiI and DiD. DiI travels both anterogradely and retrogradely along lipid membranes, enabling us to examine both fiber trajectories and cell morphologies. Satb2 IHC of DiI-labeled cells showed that 70% of the callosally projecting neurons were Satb2 immunoreactive in WT animals at P0. It is not clear why the remaining Satb2À cells failed to cross the midline; one possibility is that Satb2À axons require Satb2+ pioneer axons to guide them (Rash and Richards, 2001) . DiI labeling of a.c in WT animals at P0 also revealed that most of the back-labeled cortical neurons were from the insular cortex, 37% of which are normally Satb2+ ( Figure 3G ). In the absence of the c.c, 58% of DiI-labeled cells were Cre+, and they were seen originating from a more dorsal position in the cortex (e.g., parietal cortex, including putative somatosensory cortex) than is normal in WT animals ( Figure 3G ). This finding was further investigated by placing DiI in the presumptive somatosensory area, which allowed the anterograde labeling of corticofugal axons. Cortical axons from the presumptive somatosensory area travel via the external capsule to the a.c in KO ( Figure 3H ) mice. However in WT animals, axons from the same area were seldom seen projecting to the a.c (n = 3) ( Figures 3H and 3H ). In WT mice, neurons from the insular cortex also send callosally projecting axons. In a DiI/DiD double-label experiment where DiI was placed in the c.c and DiD was placed in the a.c, no doublelabeled cells were found in the WT parietal cortex (data not shown), indicating that there are no dual projections within the parietal cortex that project to both the c.c and the a.c.
Afferent and Efferent Cortical Axon Connections in Satb2 Mutants Are Misrouted
The expression of Satb2 coincides with the period during which major cortical afferent and efferent connections are established, such as the corticothalamic and thalamocortical projections, as well as pathways leaving through the cerebral peduncle. We used DiI to label different pathways from the cortex, thalamus, internal capsule, and cerebral peduncle. At P0, DiI was placed in the presumptive somatosensory area in order to both anterogradely label corticofugal axons (CFAs) and retrogradely label thalamocortical axons (TCAs) and thalamic projection neurons. In Satb2 À/À brains, the corticofugal connection through the internal capsule was shifted to a more caudal position, and fewer cell bodies were labeled in the cortex. On the other hand, thalamocortical axons were normal in Satb2 mutant brains, as cell bodies in the ventrobasal complex of thalamus (VB) were retrogradely labeled ( Figures 4A-4C ) after S1 cortical DiI crystal placements. DiI placed into the VB or dorsal thalamus anterogradely labeled TCAs and retrogradely labeled CFAs from the somatosensory area. Moreover, TCA fibers projected normally via the internal capsule to the cortex. However, similar to the corticofugal pathway, the trajectory of thalamocortical pathway was also shifted to a more posterior level in mutants. Thalamocortical innervation in the cortex was generally reduced, and there were also fewer back-labeled corticofugal neurons in the KO cortex ( Figures  4D-4F ).
We also examined whether the distribution of subcortically projecting neurons, which predominantly originate from deep layers 5 and 6, was also altered in Satb2 mutants. We placed DiI in the internal capsule or cerebral peduncle at P0. We found that the number of subcortically projecting neurons present in the differentiating cortical plate of mutants increased from 1.69% to 6.10% in the cerebral peduncle (n = 1047) and from 13.10% to 21.52% in the internal capsule (n = 869) (Figures 4G and 4H) . Colocalization of DiI labeling from the cerebral peduncle with Satb2 or Cre IHC further showed that the loss of Satb2 resulted in an increase in the number of neurons in mutants (from 37% in WT to 64%) that send efferent connections to subcortical targets. Of note, there is a small population of cells that express both Satb2 and Ctip2, but these Satb2+ cells were never seen projecting to the spinal cord in WT mice (n = 87) ( Figure 4I ). Since Satb2 mutants die after birth, we could not compare data between mutants and WT animals at later time points.
All the DiI and IHC colocalization data (including the previous section) are summarized ( Figure 4J ). This table indicates that Satb2-expressing neurons normally send their axons via the corpus callosum, anterior commissure, or internal capsule, but never to the spinal cord. Without Satb2, the corpus callosum failed to form, and Cre-expressing UL neurons sent axons to targets that normally form connections with deep-layer neurons, e.g., the anterior commissure and the cerebral peduncle.
Satb2 Ablation Leads to Impaired Migration of Upper-Layer Neurons
In order to investigate whether neuronal migration was affected by Satb2 deletion, we performed additional BrdU pulse experiments. Pregnant females were injected with BrdU at E13.5, E15.5, and E17.5, and the brains were analyzed at P0. High levels of BrdU were detected in cells that were undergoing their last mitotic cycle at the time of injection. Analysis of the distribution of BrdU+ cells in the CP at later stages allowed us to examine the pattern of migration of these cells. Most cells born at E13.5 become DL neurons, with a minor fraction of them becoming Satb2+ (Britanova et al., 2006a) . Both the number of BrdUlabeled cells and the size of the domain occupied by them were similar in WT and KO animals ( Figures 5A and 5B) . However, the entire population of BrdU+ cells was shifted toward the upper part of the CP in mutant animals, whereas no BrdU+ cells were detected in this area in WT mice. These findings indicate that the migration of neurons born at E13.5 was not affected by Satb2 deletion. In contrast, cells labeled at E15.5 did not migrate properly in the absence of Satb2. Most of the cells born at E15.5 occupied the upper cortical layers in both WT and mutant mice, but they were more dispersed in the latter ( Figures 5C and  5D ). Migration of cells born at E17.5 did not seem to be affected in mutant animals. At P0 both in WT and KO brains, BrdU+ cells were found in the VZ/SVZ, IZ, and CP ( Figures 5E and 5F ).
In utero electroporation was used as a means to follow the migration of Satb2-deficient cells in postnatal brains and to investigate whether Satb2 affects migration cell-autonomously. At E15.5, a plasmid expressing shRNA against Satb2 and eGFP mRNA was injected into one lateral ventricle and electroporated. The contralateral side was electroporated with a plasmid expressing mRFP only, and the distribution of transfected cells was studied at either P0 or P14. At P0, many of the transfected cells were found in the CP of the mRFP-injected cortical hemispheres, while none of the Satb2 shRNA transfected cells reached the CP (Figures 5G and 5H) . Interestingly, this migration defect seems to be corrected by P14, as no apparent differences were noted in the distribution of shRNA-and control plasmidinjected cells in the cortex (Figures 5I and 5J) .
In summary, Satb2-deficient cells failed to migrate past neurons born earlier and attain their proper outer-layer position in Satb2 KO mice. Moreover, even a decreased level of Satb2 (e.g., by using shRNA) led to impairment of cell migration, demonstrating that Satb2 0 s function in the control of cell migration appears to be cell-autonomous.
Satb2 Is Required Cell-Autonomously to Maintain a Genetic Program for Upper-Layer Cells
To determine whether the lack of Satb2 affects cell-type-specific genetic programs in the developing neocortex, we analyzed the expression of several layer-specific genes. Using ISH or IHC, we addressed whether there were any changes in the expression of upper-layer-expressed genes such as Brn2, Cux2, and Svet1 (McEvilly et al., 2002; Nieto et al., 2004; Sugitani et al., 2002; Tarabykin et al., 2001; Zimmer et al., 2004) in Satb2 mutants. We found no significant differences in the number of Brn2+ (Supplemental Data) or Cux2+ cells (data not shown). Svet1 is a marker of a subpopulation of upper-layers cells. These cells are not found in the CP before E18.5, and they finish their migration at P2 (Tarabykin et al., 2001) . By contrast, Satb2+ cells are present in the CP already at E15.5, a stage when Svet1-expressing cells have not yet started migrating. As a result, by E18.5 most of the Satb2+, but not Svet1+ cells, are found in the CP (Figures 7B and  7F) . Moreover, at times when both genes are expressed in the CP, they are not expressed in the same cells. In Satb2 mutant cortices, Svet1 is expressed in the CP as early as E15.5. Its expression domain coincides with the expression of the Cre reporter. This indicates that Svet1 is ectopically activated within cells that normally express Satb2 in Satb2 null mutants. Unfortunately, the lack of availability of a suitable Cre antibody presently precludes colocalization of Cre and Svet1 comparable to our earlier examination of Satb2 and Svet1 (Figures 1E-1G) .
To determine whether the expression of DL genes was also affected in Satb2 À/À mice, we performed ISH and IHC with several deep-layer markers. ISH of the layer 5 marker Er81 ( Figures 7D  and 7H ) and layer 4 marker RoRb (data not shown) showed that their expression domains were not altered in E15.5 and E17.5 mutant brains; Fezf2 expression was also not affected by the Satb2 mutation (data not shown). The expression of Tbr1, a gene important for proper specification of layer 6 and subplate neurons, was affected by the Satb2 deletion. In the wild-type mice, Tbr1 is expressed at high levels in the subplate and layer 6 neurons and at low levels in UL neurons (Hevner Figure 6B ). Although its expression in DL cells (highexpressing cells) was not affected by Satb2 mutation, its expression in the UL cells (low-expressing cells) was downregulated ( Figure 7E ).
The transcription factor Nurr1 is expressed in the subplate medially and in addition to subplate also in upper layers laterally. Interestingly, in the medial region of the neocortex, Nurr1 was upregulated in the Satb2-positive domain. IHC with an anti-Nurr1 antibody demonstrated that, in the medial neocortex, Nurr1 is ectopically activated in Satb2-expressing cells ( Figures 7C,  7G , 7I, and 7J). In contrast, in the lateral cortex, Nurr1 is expressed in Satb2-expressing cells. Satb2 ablation in this region leads to a shift of Nurr1 expression, such that it appears within the deeper part of the CP. The number of Nurr1-expressing cells in the lateral cortex does not seem to be significantly affected ( Figures 7C and 7G) .
Another gene that is expressed strongly in the developing neocortex and required for its normal development is Sip1 (Miquelajauregui et al., 2007; our unpublished data). It is highly expressed in virtually all UL neurons but also in many DL neurons, although at a lower level ( Figure 6C ). We analyzed the colocalization of Satb2 and Sip1 by comparing Cre and Sip1 expression in Satb2 +/À mice. Almost all Sip1 neurons in the upper layers coexpressed Cre. In deep layers, a minor population of cells that expressed Sip1 at high levels also coexpressed Cre. Most cells in deep layers expressed Sip1 at low levels and did not express Cre.
Sip1 expression in Satb2
À/À UL neurons was strongly downregulated. However, Sip1 expression in DL cells was maintained at normal levels in mutant mice. Additionally, there were scattered cells in upper layers that did not downregulate Sip1 expression. The cells that did not inactivate Sip1 in Satb2 mutant brains did not express Cre either, indicating that they still maintained Satb2 expression ( Figure 6H ). We did not perform Sip1/Satb2 double-IHC in this study. However, experiments described above (''Satb2 Protein Is Not Detected in Most Neocortical Cells of Satb2 À/À Mice and Its Deletion Does Not Induce Apoptotic Cell Death in the Neocortex'') demonstrate that Cre and Satb2 expression in the Satb2 À/À brains is mutually exclusive. Additional in situ hybridization experiments with dorsal or medial cortex specific molecular markers (Id2, Oct6, Fzd8, Sfrp1) did not reveal any abnormalities in areal specification in Satb2 mutants (data not shown; Figure S5 ).
Ctip2 is a transcription factor that controls specification of DL neurons. Specifically, Ctip2 is required for formation of the corticospinal tract . Most Satb2+ cells do not coexpress Ctip2 ( Figure 6A ). Satb2 ablation changes Ctip2 expression dramatically. Virtually all Cre-expressing cells in Satb2 À/À mice also expressed Ctip2 ( Figure 6J ). Interestingly, single cells that did not show Ctip2 immunoreactivity in the mutant cortex were the same cells that retained Satb2 immunoreactivity.
In summary, these results indicate that Satb2 is required to activate a genetic program within early UL neurons (high Sip1 expression, low Tbr1 expression) and conversely inactivate expression of genes specific for other neocortical sublineages, such as DL cells (Ctip2 and Nurr1 expression) and late UL cells (Svet1 expression). Our analysis of cortical cells in the mutant that failed to inactivate Satb2 indicates that Satb2 is required cell-autonomously for the genetic program utilized in earlyborn UL neurons.
Satb2 Expression in DL Cells Induces Ctip2 Downregulation and Impairs Development of the Corticospinal Tract
We used ex vivo electroporation to study the effect of ectopic Satb2 expression in DL cells. In these experiments, we injected a Satb2 cDNA expressing plasmid together with a GFP plasmid into the lateral ventricles of E13.5 ''whole head'' preparations, and then electroporated. Electroporated brains were sectioned, and slices were incubated for 2 or 3 days in culture. Most GFP+ cells activated Satb2 expression (data not shown). We then monitored Ctip2 gene expression in GFP-expressing cells ( Figures  7K and 7L ). Ectopic Satb2 expression had a strong effect on Ctip2 expression. Only 12% of GFP-positive cells coexpressed Ctip2. In contrast, in control experiments where only GFP plasmid was electroporated, 55% of GFP-positive cells also expressed Ctip2 ( Figure 7Q ). .29, n = 3; Satb2 À/À 88.57 ± 9.14, n = 2).
In order to address whether Satb2 downregulation coincides with abnormal development of the corticospinal tract, we used the same construct for in utero electroporation and looked at the connectivity of GFP-positive cells. The embryos were electroporated at E13.5 and were analyzed at either P0 or P7, using GFP fluorescence to visualize neurites. This approach allowed us to examine the contribution of GFP-labeled axons to different cortical tracts. Neurons electroporated with a control plasmid contributed their axons to all major cortical tracts, including the c.c, the a.c, the internal capsule, the external capsule, and the cerebral peduncle. Similarly, in the case of Satb2 overexpression, GFP-positive axons were found in the c.c, the a.c, the internal capsule, and the external capsule, but in contrast to control experiments, they were not detected in the cerebral peduncle ( Figures 7M-7P ) (n = 6). This phenotype resembles that observed in Ctip2 KO mice, where layer 5 corticospinal neurons often fail to extend their axons to the pons .
Satb2 Protein Interacts with Both the Ctip2 Upstream Promoter Region and the Histone Deacetylase Complex and Controls Chromatin Remodeling
Satb1, the closest homolog of Satb2, was shown to interact with specialized AT-rich DNA sequences (MARs/SARs, Matrix/Scaffold Attachment Regions; and BURs, Base Unpairing Regions) and controls the expression of multiple genes (Alvarez et al., 2000; Cai et al., 2003; de Belle et al., 1998; Yasui et al., 2002) . We have shown that Satb2 in the cortex is part of a protein complex that can interact with different MAR and AT-rich DNA sequences in the cortex in vitro (Britanova et al., 2005; Szemes et al., 2006) . We therefore investigated whether the Ctip2 genomic locus contains DNA sequences that can be recognized by the Satb2-containing protein complex. Two computer algorithms, MAR-Wiz (http://www.futuresoft.org/MAR-Wiz) and SMARTest (http://www.genomatix.de/; Genomatix Software, Munich), were used to predict MARs in the vicinity of the Ctip2 transcription start site. Both programs revealed a single region located 3500 bp upstream of the Ctip2 transcription start site. This DNA fragment was amplified by PCR, radioactively labeled, and subjected to a binding reaction with nuclear proteins extracted from E17.5 cortical cells. This assay resulted in a DNA mobility shift, indicating that there is a protein complex in the cortical cells capable of interacting with the sequence. Addition of an unlabeled MAR DNA fragment in a concentration-dependent manner depleted the appearance of this band, confirming the specificity of the DNA/protein interaction. Inclusion of an anti-Satb2-specific antibody in the DNA mobility shift assay ''supershifted'' the specific band ( Figure 8B) .
In order to address whether this interaction takes place in cortical cells in vivo, we applied a chromatin immunoprecipitation assay (ChIP) using a Satb2 antibody. A Satb2 protein/Ctip2 DNA complex was detected by semiquantitative PCR with several pairs of primers complementary to sites within 10 kb of the Ctip2 upstream region. The ChIP assay demonstrated that Satb2 protein was detected within the 3.5 kb upstream region of the Ctip2 transcription start. However, this antibody failed to precipitate any DNA from Satb2 mutant tissue ( Figure 8C ).
We applied a similar approach to ask whether chromatin remodeling at the Ctip2 locus was affected in the Satb2 deletion mutant. Using ChIP with antibodies specifically recognizing acetylated or methylated forms of histone H4, we demonstrated that the Ctip2 locus is strongly hyperacetylated in the cortical cells of Satb2 mutants as compared to wild-type littermates. In contrast, the level of H4 methylation of Ctip2 locus did not seem to be changed ( Figure 8C ).
Next we asked if Satb2 directly interacts with chromatin remodeling proteins. Satb1, the closest Satb2 homolog, has been shown to interact with components of the NURD chromatin remodeling complex (Yasui et al., 2002) . To test if this is also the case for Satb2, we immunoprecipitated nuclear proteins isolated from E18 rat cerebral cortex with a Satb2-specific antibody. We selected rat rather than mouse cerebral cortex for these experiments to enable easier isolation of sufficient quantities of cortical tissue from rat embryonic brains. We specifically tested whether two members of the NURD complex, histone deacetylases HDAC1 and MTA2, interact with Satb2 using a coimmunoprecipitation assay. Immunoblots showed that both MTA2 and HDAC1 are coprecipitated with Satb2 in the presence of Satb2 antibody ( Figure 8D ). As no Satb2, HDAC1, or MTA2 immunoreactivity was detected when using the control antibody, these experiments indicate that, in the developing cortex, Satb2 interacts with HDAC1 and MTA2.
In order to find if the NURD chromatin remodeling complex interacted with the Ctip2 locus and whether this interaction was affected by a Satb2 mutation, we analyzed occupancy of HDAC1 and MTA2 at this locus in both wild-type and mutant P0 brains. The ChIP experiments with HDAC1 and MTA2 antibodies revealed that both proteins interact with the Ctip2 locus. Importantly, the interaction was substantially reduced (3-to 6-fold) although not completely abolished in Satb2 mutants ( Figure 8C ). This in vivo interaction is specific, since the negative control region (GAPDH) was not amplified from samples precipitated with either of the antibodies, only from the nonimmunoprecipitated positive (input) control. There was no difference between the mutant and the wild-type samples in this region.
It is worth mentioning that in all ChIP experiments the entire cortex was used. Such samples also contain many cells that did not express Satb2. This suggests that differences in acetylation and NURD complex occupancy of the Ctip2 locus specifically in UL cells are substantially higher than we detected.
Together, these data strongly suggested that Ctip2 is a direct target of Satb2 in the developing neocortex and that Satb2 downregulates Ctip2 expression via the assembly of a NURD chromatin remodeling complex at the Ctip2 locus.
DISCUSSION
Here we show that the MAR-binding protein Satb2 is required for cell-type specification of UL neurons in the neocortex. We found that Satb2-deficient UL neurons failed to form the corpus callosum, a major fiber tract that interconnects UL neurons between the cerebral hemispheres. Instead, at least some UL neurons send their axons toward the cerebral peduncle, a feature normally exclusively associated with layer 5 neurons. The lack of the corpus callosum is also accompanied by an increase in the thickness of the anterior commissure, another bundle of fibers interconnecting the two hemispheres. As shown in DiI tract labeling, this thickness increase in the a.c is likely to be a result of c.c fibers misrouted to the a.c from a more dorsal region of the cortex (e.g., from parietal and frontal cortical areas). This may also explain the absence of Probst bundles, as fewer callosal axons arrive at the midline. Many Satb2-deficient UL neurons failed to migrate into their normal superficial location and settled instead within the DL territory. However, the migration of DL neurons does not seem to be affected in Satb2 À/À mutants, indicating that the effect of Satb2 on migration is cell-autonomous. At the level of gene expression, Satb2-deficient UL neurons upregulate expression of at least two transcription factors, Ctip2 and Nurr1, which are normally only expressed by DL neurons. We found that Satb2 and Ctip2 proteins are mutually exclusive in most neocortical cells at the time they start to establish connections with other neurons. However, there are some Satb2-expressing cells (albeit at low levels) that coexpress Ctip2. Satb2 is required to assemble NURD chromatin remodeling complex on Ctip2 locus. This induces deacetylation of histones and inactivation of Ctip2 expression. There are three major subpopulations of neocortical neurons: DL neurons express Ctip2, some of them also coexpress Satb2; UL1 neurons express Satb2 but not Ctip2; UL2 neurons express Svet1 but not Satb2. Satb2 inhibits UL2 and DL genetic programs.
of Satb2 in UL neurons is the transcription factor Sip1. Although Sip1 is expressed in both UL and DL neurons, Satb2 seems to be required for Sip1 expression only in UL neurons, as it was found to be downregulated in UL but not DL neurons in Satb2 mutants. Similar to Ctip2 expression, Sip1 was maintained in cells of the upper layers that did not inactivate Satb1, also indicating that this gene expression is mediated through a cell-autonomous regulatory mechanism. Our MAR-binding and ChIP experiments demonstrate that Satb2 protein interacts with the upstream regulatory region of Ctip2, both in vitro and in vivo. Similar to its homolog Satb1, Satb2 also interacts with HDAC1 and MTA2, members of the NURD chromatin remodeling complex. Moreover, Satb2 deletion leads to hyperacetylation of the Ctip2 locus and decreases HDAC1 and MTA2 levels at this locus. These results strongly suggest that Satb2 is required to recruit the NURD complex to the Ctip2 locus. The NURD complex in turn deacetylates histones in the vicinity, converting the chromatin to an inactivate state. Interestingly, Satb2 and Ctip2 are coexpressed in some early-born cells in deep layers. Although Ctip2 expression is weaker in these cells, Satb2 does not seem to inactivate Ctip2 expression. One possible explanation of this phenomenon is that other factors, which are missing in early-born neurons, are required for such inactivation. This however seems unlikely because in our Satb2 overexpression experiments Satb2 alone was capable of inactivating Ctip2 expression in early neurons. Another explanation is that Satb2 can prevent the onset of Ctip2 expression but cannot inactivate Ctip2 expression once it is initiated. Indeed, Satb2 starts to be expressed in the cortex later than Ctip2, but in the cells that express Satb2, its activity is detected before they arrive in the CP, while Ctip2 is not active in migrating cells. Although the effect of ectopic Ctip2 expression in the neocortex on axonal guidance has not been reported, it has been shown that Ctip2-deficient layer 5 neurons fail to extend projections to the spinal cord . Ctip2 is not expressed in callosal neurons; therefore, it is very likely that ectopic activation of Ctip2 in UL neurons of Satb2 À/À mice is the major reason for the misrouting of UL projections to the internal capsule and cerebral peduncle. This could also be the primary reason why overexpression of Satb2 in DL neurons impairs development of the corticospinal tract. Future experiments with Satb2/Ctip2 compound mutants will be required to address this issue more precisely. We analyzed axonal projections of the Satb2-positive cells. As expected, most callosally projecting cells express Satb2. However, Satb2 was also detected in many cells projecting to the anterior commissure, as well as to internal and external capsules. Conversely, we did not detect any spinal cord projecting neurons that express Satb2. Satb2 is necessary for callosal connections, as its deletion results in rerouting of callosal axons toward the anterior commissure, but does not prevent axons from going toward the internal capsule, the anterior commissure, or the external capsule. However, its overexpression does not result in rerouting of commissural connections toward the corpus callosum. It is possible that the increase in anterior commissure axons in Satb2 À/À mice is a secondary, non-cell-autonomous effect of Satb2 ablation. Our findings that Satb2 protein is not detected in young neurons for at least 9 hr after exit from the mitotic cycle and that deletion of such a late postmitotic gene leads to maintenance of some aspects of DL laminar fate are surprising. It suggests that aspects of laminar fate, such as the specificity of connections, are not terminally determined at the level of progenitors, but rather at the level of postmitotic neurons. Hence, CP neurons might have a potential to maintain some characteristics of both DL and UL longer than presently thought. This finding is unexpected because it has been shown that the decision whether a cell becomes a UL or DL neuron is taken at the time of the terminal mitotic division, and UL progenitors cannot generate DL neurons (Desai and McConnell, 2000) .
Our expression analysis of Satb2 À/À mice indicates that, although UL neurons in Satb2 À/À cortex lose their UL identity, they do not become identical to DL neurons. This is indicated by the finding that early UL neurons in Satb2 À/À mutants activate Svet1 expression. Both our previous work and the present study indicate that there are at least two distinct UL subpopulations. One subpopulation, which we term ''UL1,'' is mostly born between E14.5 and E15.5 and expresses Satb2. UL1 cells do not seem to reside in the SVZ for a long time, as we detected many of these cells in the CP as early as E14.5. Another subpopulation, ''UL2,'' expresses Svet1. UL2 cells were first detected at E13.5 in the SVZ, but seem to stay several days at this location before migrating to the CP at E17.5 (Tarabykin et al., 2001) .
Our colocalization experiments demonstrate that in the CP the expression of Svet1 and Satb2 is mutually exclusive. It is possible, however, that Satb2 cells express Svet1 in the SVZ but downregulate it before starting their migration. In Satb2
mice, Svet1 expression is ectopically activated in the CP as early as E15.5 and is very strong at E17.5. Although it was not possible to colocalize Svet1 and Satb2 in the mutant brains, we speculate that there likely is ectopic activation of Svet1 expression in Satb2 cells rather than premature migration of Svet1-expressing cells from the SVZ toward CP. Our BrdU pulse experiments rule out premature migration and demonstrate that there is a delay rather than acceleration in the migration of UL neurons. Upregulation of both DL-and UL2-specific genes in UL1 cells indicates that Satb2-deficient UL1 neurons have a mixed identity and that Satb2 is required to suppress other ''non-Satb2+'' cortical cell fates. Another aspect of laminar fate that is disturbed in UL1 neurons in Satb2 mutants is cell migration. This seems to result from a cell-autonomous defect because DL migration is not affected. Although we detected differences in the position of DL neurons (cells labeled by BrdU at E13.5) between WT and KO brains, these differences most probably reflect the fact that the migration of later-born UL neurons is affected. Indeed, if later-born UL cells fail to migrate past early-born DL neurons, DL neurons will de facto occupy more superficial positions. It is not clear whether abnormal migration of UL neurons in Satb2 À/À mice is due to a general delay of migration of UL1 cells or is due to mistargeted migration into deep layers. Specifically, it is not known whether there is a mechanism driving the migration of certain populations into particular cortical layers or if a general process exists to drive all cortical neurons into the most outer part of the CP, regardless of layer identity. Although targeted migration of different neuronal subtypes into appropriate neocortical layers might occur, this has not been demonstrated. Although our in utero electroporation experiments indicate that Satb2-deficient cells can eventually migrate to upper layers, it might reflect the fact that shRNA does not suppress the gene completely, and residual or recovery of Satb2 protein levels is sufficient to rescue the migration defect at later stages. Brn1 and Brn2 transcription factors have been shown to control migration of UL neurons. Expression of these transcription factors was not affected by Satb2 mutation. It will be important to investigate whether Satb2 acts downstream of Brn1/2 or if it is involved in a different pathway.
In summary, our data suggest that Satb2 is a crucial mediator for the specification of UL1 neurons. It is required to initiate the UL1-specific genetic program and to inactivate the expression of DL-and UL2-specific genes. Our data also suggest that, at the molecular level, Satb2 is required to assemble the NURD chromatin remodeling complex in order to prevent the expression of inappropriate (i.e., DL-specific) genes.
EXPERIMENTAL PROCEDURES Mice
All animal experiments were carried out in accordance with German law and were approved by the Bezirksregierung Braunschweig. Genotyping was performed as described in the original report (Britanova et al., 2006b ). The day of vaginal plug was considered embryonic day (E) 0.5.
In Situ Hybridization, Immunohistochemistry
Radioactive and nonradioactive in situ hybridization (ISH) were performed as in Miquelajauregui et al. (2007) . For immunohistochemistry (IHC), sections were washed in PBS, blocked in 1% BSA / 0.5% Tween-20 / PBS for 1 hr and incubated with primary antibodies overnight at 4 C in the same solution. Sections were then washed and incubated for 1 hr with either biotinylated secondary antibodies that were viewed by the ABC method (Vector) with diaminobenzidine (DAB) or with fluorescence-conjugated secondary antibodies. In the case of double ISH/IHC, ISH was performed without proteinase treatment and was followed by IHC.
Carbocyanine Dye Tracing
Single DiI crystals (Molecular Probes) were placed either in the ventrobasal complex of the thalamus or presumptive primary somatosensory cortex to trace thalamocortical and corticofugal axons. Several (three to four) DiI crystals were placed in the cerebral peduncle or internal capsule to study the distribution of projection neurons in the cortex. (see Molná r and Cheung, 2006, for details.) To study the origin of neurons projecting to the corpus callosum (c.c) or anterior commissure (a.c), brains were bisected sagittally. In normal brains, DiI crystals were placed along the entire length of the c.c and DiD in the a.c. In KO, only DiD was placed in the a.c.
All tract tracing was performed in P0 animals. Brains were kept in the dark for 3 weeks at room temperature for DiI diffusion, then sectioned at 50-80 mm on a vibratome (Leica). At least two animals were used per phenotype.
Nuclear Matrix Preparation and In Vitro Binding of MARs
Cortical hemispheres from either P0 pups or E17.5 embryos were surgically removed and used for nuclear extract isolation. Nuclear extracts were prepared by a high-salt extraction method (Cockerill and Garrard, 1986) . Binding of radioactively labeled MARs to the nuclear extract in vitro was carried out as described by Izaurralde et al. (1988) .
Semiquantitative Chromatin Immunoprecipitation and Coimmunoprecipitation Assay
The assay was performed using the EZ-ChIP Kit (Upstate) according to the manufacturer's instructions. Details of the procedure and primer sequences are described in the Supplemental Data. The following antibodies were used for ChIP: rabbit polyclonal anti-HDAC1 and anti-MTA2, H 4 K12 ab1761, H4 K16 ab1762 (all Abcam (UK). The coimmunoprecipitation assay is described in the Supplemental Data.
Ex Vivo and In Utero Electroporation
Ex vivo and in utero electroporation were performed as described (Hand et al., 2005) . Detailed information on the generation of the Satb2 siRNAs, overexpression vector, and the appropriate control constructs is available in the Supplemental Data.
Additional methods (BrdU pulse labeling, neuronal back-labeling using fluorescent latex microspheres) are given in the Supplemental Data.
Supplemental Data
The Supplemental Data for this article can be found online at http://www. neuron.org/cgi/content/full/57/3/378/DC1/.
